Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q1 2023 · 10-Q
Revenue$4.15M$4.15M−6.7% vs Q1 2022 Net Income$5.71M$5.71MN/M vs Q1 2022 EPS Diluted$0.04$0.04N/M vs Q1 2022 Gross Profit$1,782,000+54.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flow$975,000N/M Margins · derivedGross margin43.0%+17.0 pt vs Q1 2022
Operating margin138.9%+173.0 pt vs Q1 2022
Net margin137.6%+187.4 pt vs Q1 2022
ended Mar 31, 2023 · filed May 15, 2023 · 45 d after period end